Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Drug Approval Processes Around the World: Focus on China
lungcanc
The Fourth IASLC Screening Strategy Advice Committee CT Screening Workshop
lungcanc
Impact of Clinical Pathways on Lung Cancer Management
lungcanc
Breaking News Briefs
lungcanc
First Congress of Interventional Pulmonology & EBUS and the XI South...
lungcanc
Lung Cancer in Never-Smokers: An Epidemiologic Perspective
lungcanc
Sumitra Thongprasert, MD
lungcanc
Gerard A. Silvestri, MD, MS, FCCP
lungcanc
John C. Ruckdeschel, MD
lungcanc
Ugo Pastorino, MD
lungcanc
1
...
40
41
42
...
53
Page 41 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS